Sahu Ajaykumar C, Akhade Kiran S
Former Junior Resident, Department of Community Medicine, Lokmanya Tilak Municipal Medical College, Sion, Mumbai, Maharashtra, India.
Currently Assistant Professor, Department of Community Medicine, Raipur Institute of Medical Sciences, Raipur, Chhattisgarh, India.
J Family Med Prim Care. 2022 Jul;11(7):3622-3627. doi: 10.4103/jfmpc.jfmpc_2099_21. Epub 2022 Jul 22.
HIV/AIDS is a serious public health, economic and social problem. Stigma is a common human reaction to disease and discrimination follows stigma. Stigma and discrimination act as impediments to uptake of HIV testing, treatment, care and adherence to treatment.
The aim of this study was to estimate the prevalence of the stigma and discrimination faced by HIV positive patients receiving antiretroviral therapy (ART).
A cross-sectional, observational study conducted at ART center of a tertiary care hospital in an urban area.
Participants were selected by simple random sampling among HIV positive patients. A predesigned, pretested and self-administered, semi-structured questionnaire in local language was used to assess stigma and discrimination.
The data were entered in Microsoft Excel and analyzed with SPSS version 20 statistical software. Simple proportions, mean, standard deviation, median, range and inter-quartile range were calculated.
Of 336 participants, 170 were male, whereas 166 were females. The mean age was 36.42 years. The total mean scores for Berger's HIV stigma scale experienced was 122.82, whereas for individual subscale Personalized stigma, Negative self-image, public attitudes and disclosure of HIV status were 38.31, 27.46, 33.09 and 23.97, respectively. The maximum participants expressed the stigma regarding disclosure concerns (58.63%) followed by negative self-image stigma (43.45%).
Stigma hurdles the delivery of effective medical social care. People Living with HIV and AIDS (PLWHA) need to have greater involvement in their care, support and treatment. Support groups of PLWHA need to be established so that stigma and discrimination at various levels can be challenged collectively.
艾滋病毒/艾滋病是一个严重的公共卫生、经济和社会问题。耻辱感是人类对疾病的常见反应,而歧视则紧随耻辱感而来。耻辱感和歧视阻碍了艾滋病毒检测、治疗、护理以及坚持治疗。
本研究的目的是估计接受抗逆转录病毒疗法(ART)的艾滋病毒阳性患者所面临的耻辱感和歧视的发生率。
在市区一家三级护理医院的抗逆转录病毒治疗中心进行的横断面观察性研究。
通过简单随机抽样从艾滋病毒阳性患者中选取参与者。使用以当地语言预先设计、预先测试且自行填写的半结构化问卷来评估耻辱感和歧视。
数据录入Microsoft Excel,并使用SPSS 20版统计软件进行分析。计算简单比例、均值、标准差、中位数、范围和四分位间距。
在336名参与者中,170名是男性,166名是女性。平均年龄为36.42岁。所经历的伯杰艾滋病毒耻辱感量表的总平均分为122.82,而个性化耻辱感、负面自我形象、公众态度和艾滋病毒状况披露等各个子量表的平均得分分别为38.31、27.46、33.09和23.97。大多数参与者表达了对披露问题的耻辱感(58.63%),其次是负面自我形象耻辱感(43.45%)。
耻辱感阻碍了有效的医疗社会护理的提供。艾滋病毒感染者和艾滋病患者需要更多地参与到他们的护理、支持和治疗中。需要建立艾滋病毒感染者和艾滋病患者支持小组,以便共同应对各级的耻辱感和歧视。